JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Republic Bancorp
RBCAA
$1.92B
| $2.18M | ﹤0.01% |
57,316
-175
| -0.3% | -$7.03K |
|
|
SWCH
3127
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $2.18M | ﹤0.01% |
+119,750
| New | +$2.19M |
|
3128
Provident Financial
PROV
$113M
| $2.17M | ﹤0.01% |
117,948
+32,787
| +39% | +$630K |
|
3129
Integra LifeSciences
IART
$1.42B
| $2.17M | ﹤0.01% |
45,221
+44,025
| +3,681% | +$2.15M |
|
3130
iShares Core S&P Total US Stock Market ETF
ITOT
$98.5B
| $2.17M | ﹤0.01% |
35,406
+216
| +0.6% | +$12.9K |
|
|
XIN
3131
DELISTED
Xinyuan Real Estate
XIN
| $2.16M | ﹤0.01% |
31,754
+6,007
| +23% | +$353K |
|
3132
CALL
Royal Caribbean
RCL
$82.9B
| $2.16M | ﹤0.01% |
18,100
-19,800
| -52% | -$2.45M |
|
3133
Smith & Wesson
SWBI
$643M
| $2.16M | ﹤0.01% |
218,395
-74,390
| -25% | -$804K |
|
3134
Enova International
ENVA
$6.52B
| $2.15M | ﹤0.01% |
141,681
+116
| +0.1% | +$1.7K |
|
3135
VanEck Junior Gold Miners ETF
GDXJ
$8.33B
| $2.15M | ﹤0.01% |
62,903
+21,580
| +52% | +$704K |
|
3136
ProShares Russell 2000 Dividend Growers ETF
SMDV
$708M
| $2.15M | ﹤0.01% |
+38,894
| New | +$2.19M |
|
|
FFWM
3137
DELISTED
First Foundation Inc
FFWM
| $2.14M | ﹤0.01% |
115,218
+5,518
| +5% | +$102K |
|
|
AMED
3138
DELISTED
Amedisys
AMED
| $2.13M | ﹤0.01% |
40,404
+30,008
| +289% | +$1.58M |
|
|
MODV
3139
DELISTED
ModivCare
MODV
| $2.12M | ﹤0.01% |
+35,783
| New | +$2.03M |
|
3140
Cable One
CABO
$206M
| $2.12M | ﹤0.01% |
3,017
-14,287
| -83% | -$10.1M |
|
|
AY
3141
CALL
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $2.12M | ﹤0.01% |
+100,000
| New | +$2.18M |
|
3142
US Physical Therapy
USPH
$1.24B
| $2.12M | ﹤0.01% |
29,348
+3,100
| +12% | +$211K |
|
3143
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $2.12M | ﹤0.01% |
111,540
+2,000
| +2% | +$37K |
|
|
ALOG
3144
DELISTED
Analogic Corp
ALOG
| $2.12M | ﹤0.01% |
25,295
+19,303
| +322% | +$1.6M |
|
3145
Matador Resources
MTDR
$6.39B
| $2.12M | ﹤0.01% |
67,929
+61,879
| +1,023% | +$1.7M |
|
3146
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
| $2.11M | ﹤0.01% |
27,378
+26,226
| +2,277% | +$2.02M |
|
3147
News Corp Class B
NWS
$17.8B
| $2.1M | ﹤0.01% |
126,785
+84,427
| +199% | +$1.29M |
|
3148
CALL
eBay
EBAY
$46.5B
| $2.1M | ﹤0.01% |
55,700
-107,800
| -66% | -$4M |
|
|
EXAS
3149
CALL
DELISTED
Exact Sciences
EXAS
| $2.1M | ﹤0.01% |
+40,000
| New | +$2.14M |
|
|
EXAS
3150
PUT
DELISTED
Exact Sciences
EXAS
| $2.1M | ﹤0.01% |
+40,000
| New | +$2.14M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.